5 курс / Пульмонология и фтизиатрия / Колосов_В_П_,_Кочегарова_Е_Ю_,_Нарышкина_С_В_Внебольничная_пневмония

against a radiographic standard // Scand. J. Prim. Health Care. – 1992. – Vol. 10. – P. 226-233.

196.Menender R., Martinez R., Reyes S. Biomarkers improve mortality prediction diagnostic scales in community-acquired pneumonia // Thorax. – 2009. – Vol. 64 (7). – P. 587-591.

197.Messer J., Eyer D., Donato L., et al. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection // J. Pediatr. – 1996. – Vol. 129. – P. 574-580.

198.Metlay J.P., Kapoor W.N., Fine M.J. Does this patient have communityacquired pneumonia? Diagnosing pneumonia by history and physical examination // JAMA. – 1997. – Vol. 278. – P. 1440-1445.

199.Mimoz O., Benoist J., Edouard A. et al. Procalcitonin and C-reactive protein during the early posttraumatic syndrome // Intensive Care Med. – 1998. – Vol.

24.– P. 185-188.

200.Monneret G., Issaac C. Procalcitonin and C-reactive protein levels in neonatal infections // Acta Pediatr. – 1997. – Vol. 86. – P. 209-212.

201.Monneret G., Labaune J.M., Isaac C. et al. Procalcitonin and C-reactive protein levels in neonatal infections // Acta Paediatr. – 1997. – Vol. 86. – P. 209-212.

202.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis / E. Nylen [et al.] // Crit. Care Med. – 1998. – Vol. 26. – P. 1001-1006.

203.Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit / B. Muller [et al.] // Crit. Care Med. – 2000. – Vol. 28. – P. 977-983.

204.Navas B., Krammer I., Shah P. Procalcitonin in diagnosis of severe infections // Eur. J. Med. Res. – 1996. – Vol. 1. – P. 331-333.

205.Nijsten M.W., Olinga P. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro // Crit. Care Med. – 2000. – Vol. 28. – P. 458-461.

206.Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecules, and C-reactive protein in preterm very low birthweight ifants / P.C. Nyg [et al.] // Arch Dis Child Fetal Neonatal Ed. –1997. –Vol. 77. – P. 221-227.

207.Nylen E.S., Whang K.T. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis // Crit. Care Med. – 1998. – Vol. 26 (6). – P. 1001-1006.

208.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis / E.S. Nylen [et al.] // Crit. Care Med. – 1999. – Vol. 28. – P. 1038-1041.

209.Рrocalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis / E.S. Nylen [et al.] // Crit. Care Med. – 2000. – Vol. 37. – P. 1112-1116.

210.Oberhoffer M., Bigel M. PCT as immunological markers infection // Brit. J. Anaesth. – 1996. – Vol. 76. – P. 352.

211.Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis / M. Oberhoffer [et al.] // Crit. Care. Med. – 1999. – Vol. 27. – P. 1814-1818.

212.Oberhoffer M., Kazai W., Reinhart K. Procalcitonin a new diagnostic parameter for severe infections and sepsis // Anaesthesist. – 1998. – Vol. 47 (7). – P. 581-587.

213.Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lypopolysacharides and sepsis related cytokines in vitro / M. Oberhoffer [et al.] // J. Lab. Clin. Med. – 1999. – Vol. 134. – P. 29-33.

214.Oberhoffer M., Vogelsang H., Russwurm S. Outcome prediction by traditional and new markers of inflammation in patients with sepsis // Clin. Chem. Lab Med. – 1999. – Vol. 37. – P. 363-368.

215.Induction de la procalcitonine circulante après administration intraveineuse d’endotoxine chez I’homme / S. Petitjean [et al.] // Acta Pharm. Biol. Clin. – 1994. – Vol. 1. – P. 265-268.

216.Philip A.G., Mills P.C. Use of C-reactive protein in minimizing antibiotic exposure // Nyt. New England J. of medicine. – 2000. – Vol. 106. – P. 106-104.

217.Validation and clinical implications of the IDSA/ATS minor criteria of severe community - acquired pneumonia. / J. Phua [et al.] // Thorax. – 2009. – Vol.64, (7). – P.598–603.

218.Pourcyrous M., Bada H.S. Significance of serial C-reactive protein responses in neonatal infection and other disordes // Pediatrics. – 1994. – Vol. 106. – P. 4.

219.Reinhart K., Karzai W., Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection // Intensive Care Med. – 2000. – Vol. 26. – P. 1193-1200.

220.Evaluation of four automated high sensitivity C-reactive protein method: implications for clinical and epidemiological applications / W.L. Roberts [et al.] // Clin. Chem. – 2000. –Vol. 46. – P. 461-468.

221.Ruokonen E., Ilkka L. Procalcitonin and neopretin as indicators of infection in critically ill patients // Acta Anaesth. Scand. – 2002. – Vol.46. – P.398–404.

222.Procalcitonin as monocyte marker for early diagnosis in septic aborts / S. Russwurms [et al.] // Neonatal. – 1999. – Vol. 14. – P. 29-33.

223.Smith R.P., Lipworth B.J. C-reactive protein in simple communityacquired pneumonia // Chest. – 1995. – Vol. 60. – P. 8-26.

224.Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children / P. Toikka [et al.] // Pediatr. Infect. Dis. J. – 2000. – Vol. 19. – P. 598-602.

225.Turner D., Hammerman C., Rudensky B. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants // Acta. Paediatricia. – 2006. – Vol. 95 (12). – P. 1571-1576.

226.Procalcitonin used as marker of infection in the medical intensive care unit / H. Ugarte [et al.] // Crit. Care Med. – 2000. – Vol. 28. – P. 977-983.

227.Victor van deer Meer. Diagnostic value of C-reactive protein in infections of the lower respiratory tract: systematic review // BMJ. – 2005. – Vol. 331 (26). – P. 142-148.

228.Vigushin D., Pepys M., Hawkins P. Metabolic and scintigraphic studies of radiodinated human C-reactive protein in health and disease // J. Clin. Invest. – 1993.

–Vol. 91. – P. 1351-1357.

229.Volante E., Moretti S. Early diagnosis of bacterial infection in the neonatale // J. of Mat.-Fetal and Neonat. Med. – 2004. – Vol.16 (2). – P. 13-16.

230.Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients / G.A. Wanner [et al.] // Crit. Care Med. – 2000. – Vol.28. – P. 950–957.

231.Procalcitonin and proinflammatory cytokine interactions in sepsis / K.T. Whang [et al.] // Shock. – 2000. – Vol. 14.– P. 73-78.

232.Wicher J., Bienvenu J., Monneret G. Procalcitonin as an acture phase marker //Ann. Clin. Biochem. – 2001. – Vol.38. – P. 438-493.

233.Procalcitonin serum concentrations and severity of sepsis / F. Zeni [et al.] // Suppl. Clin. Intens. Care. – 1994. – Vol. 5. – P. 2.

Виктор Павлович Колосов,

член-корр. РАМН, профессор, д-р мед. наук, Заслуженный деятель науки Российской Федерации, директор ФГБУ «Дальневосточный научный центр физиологии и патологии дыхания» Сибирского отделения РАМН

Екатерина Юрьевна Кочегарова,

канд. мед. наук, научный сотрудник лаборатории профилактики неспецифических заболеваний легких ФГБУ «Дальневосточный научный центр физиологии и патологии дыхания» Сибирского отделения РАМН

Светлана Владимировна Нарышкина,

профессор, д-р мед. наук, зав. кафедрой факультетской терапии ГБОУ ВПО «Амурская государственная медицинская академия» Минздравсоцразвития РФ.

Внебольничная пневмония (клиническое течение, прогнозирование исходов)

Монография

Сверстано редакционной службой ФГБУ «ДНЦ ФПД» СО РАМН, 675000, Благовещенск, ул. Калинина, 22.

отпечатано в типографии «Фабрика рекламы», пер Волошина, офис 5., тел (4162) 377-570, 25-26-80

Формат 60×84/16. Усл. печ. л. 5,43. Тираж 100. Подписано к печати 26.04.12.